Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.25 AUD
16.28%
Market Closed
Updated:
May 14, 2024
Somnomed Ltd
Cost of Revenue
|
Somnomed Ltd
Cost of Revenue Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Cost of Revenue
-AU$34m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-16%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cost of Revenue
-AU$1.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cost of Revenue
-AU$10.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
|
Cochlear Ltd
ASX:COH
|
Cost of Revenue
-AU$527.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cost of Revenue
AU$815.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Cost of Revenue?
Cost of Revenue
-34m
AUD
-34m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Cost of Revenue amounts to -34m AUD.
What is Somnomed Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-16%
-16%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Somnomed Ltd have been -14% over the past three years , -7% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
